VASAMED, Inc.
VSMD
$0.00
$0.000.00%
OTC PK
| 06/30/2009 | 03/31/2009 | 12/31/2008 | 09/30/2008 | 06/30/2008 | |
|---|---|---|---|---|---|
| Revenue | 3.43M | 3.49M | 3.13M | 2.73M | 2.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.43M | 3.49M | 3.13M | 2.73M | 2.65M |
| Cost of Revenue | 1.45M | 1.47M | 1.41M | 1.53M | 1.56M |
| Gross Profit | 1.98M | 2.01M | 1.73M | 1.21M | 1.09M |
| SG&A Expenses | 2.34M | 2.56M | 2.99M | 3.33M | 3.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.05M | 5.43M | 5.87M | 6.41M | 6.74M |
| Operating Income | -1.62M | -1.94M | -2.74M | -3.68M | -4.08M |
| Income Before Tax | -1.93M | -2.21M | -2.92M | -3.78M | -4.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.93 | -2.21 | -2.92 | -3.78 | -4.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.93M | -2.21M | -2.92M | -3.78M | -4.75M |
| EBIT | -1.62M | -1.94M | -2.74M | -3.68M | -4.08M |
| EBITDA | -1.47M | -1.78M | -2.56M | -3.50M | -3.90M |
| EPS Basic | -0.24 | -0.28 | -0.37 | -0.47 | -0.81 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.23 | -0.29 | -0.51 |
| EPS Diluted | -0.24 | -0.28 | -0.37 | -0.47 | -0.81 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.23 | -0.29 | -0.51 |
| Average Basic Shares Outstanding | 32.05M | 32.05M | 32.05M | 32.05M | 27.89M |
| Average Diluted Shares Outstanding | 32.05M | 32.05M | 32.05M | 32.05M | 27.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |